CSIMarket
 


Albireo Pharma inc   (ALBO)
Other Ticker:  
 
 

ALBO's EPS from Cont. Operations Growth by Quarter and Year

Albireo Pharma Inc 's EPS from Cont. Operations results by quarter and year




ALBO EPS from Cont. Operations (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -0.57 -1.30 -0.59
III Quarter September -1.92 2.96 -1.96 -1.73
II Quarter June -2.04 -1.90 -1.38 -1.35
I Quarter March -2.19 -2.29 -2.23 -1.39
FY   -6.15 -1.80 -6.87 -5.06



ALBO EPS from Cont. Operations third quarter 2022 Y/Y Growth Comment
Albireo Pharma inc in the third quarter 2022 recorded EPS loss from Cont. Operations of $ -1.92 .

According to the results reported in the third quarter 2022, Albireo Pharma Inc achieved the best EPS from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Albireo Pharma Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2022.




ALBO EPS from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Albireo Pharma Inc 's third quarter 2022 EPS from Cont. Operations $ -1.92 ALBO's Income Statement
Albireo Pharma Inc 's third quarter 2021 EPS from Cont. Operations $ 2.96 Quarterly ALBO's Income Statement
New: More ALBO's historic EPS from Cont. Operations Growth >>


ALBO EPS from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Albireo Pharma Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ALBO's III. Quarter Q/Q EPS from Cont. Operations Comment
Although Albireo Pharma inc in the III. Quarter 2022 showed EPS loss from Cont. Operations of $ -1.92 , some analyst point out, that current results are slight up side in contrast to the -2.04 in the second quarter.

Within Major Pharmaceutical Preparations industry Albireo Pharma inc achieved highest sequential EPS from Cont. Operations growth. While Albireo Pharma Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ALBO's III. Quarter Q/Q EPS from Cont. Operations Comment
Even if Albireo Pharma inc in the III. Quarter 2022 revealed EPS loss from Cont. Operations of $ -1.92 , management point out, that those numbers are improvement in contrast to the -2.04 in the second quarter.

Within Major Pharmaceutical Preparations industry Albireo Pharma inc achieved highest sequential EPS from Cont. Operations growth. While Albireo Pharma Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Albireo Pharma Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative EPS from Cont. Operations 12 Months Ending $ -6.72 $ -1.84 $ -1.70 $ -1.80 $ -2.53
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment
Albireo Pharma Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -7 in the Sep 30 2022 period.
The results are worsening as the cumulative EPS loss from Cont. Operations is getting bigger from $ -1.84 for the period from Jun 30 2022 to Sep 30 2021 and $ -7.4474282783594 for the twelve months ending in the quarter a year ago.

Albireo Pharma inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
Albireo Pharma Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -7 in the Sep 30 2022 period.
The business is worsening as the cumulative EPS loss from Cont. Operations is becoming larger from $ -1.84 in TTM ending quarter Jun 30 2022 and $ -7.4474282783594 from the TTM period ending Sep 30 2021.

Albireo Pharma inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
ALBO's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for ALBO's Competitors
EPS from Cont. Operations Growth for Albireo Pharma Inc 's Suppliers
EPS from Cont. Operations Growth for ALBO's Customers

You may also want to know
ALBO's Annual Growth Rates ALBO's Profitability Ratios ALBO's Asset Turnover Ratio ALBO's Dividend Growth
ALBO's Roe ALBO's Valuation Ratios ALBO's Financial Strength Ratios ALBO's Dividend Payout Ratio
ALBO's Roa ALBO's Inventory Turnover Ratio ALBO's Growth Rates ALBO's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Sep 30 2022
Addus Homecare Corporation-1.35%$ -1.351 
Zoetis Inc -2.59%$ -2.586 
Ironwood Pharmaceuticals inc -2.94%$ -2.941 
Universal Health Services Inc -4.91%$ -4.906 
Henry Schein Inc-5.17%$ -5.172 
Pediatrix Medical Group Inc -5.41%$ -5.405 
Charles River Laboratories International inc -7.32%$ -7.317 
Synaptogenix Inc -8.51%$ -8.511 
Semler Scientific Inc -9.84%$ -9.836 
Sotera Health Company-10.00%$ -10.000 
National Research Corporation-10.53%$ -10.526 
Intuitive Surgical Inc -14.95%$ -14.953 
Meridian Bioscience Inc -15.08%$ -15.080 
Retractable Technologies inc -15.79%$ -15.789 
Lemaitre Vascular Inc -16.67%$ -16.667 
Molecular Templates inc -18.52%$ -18.519 
Regeneron Pharmaceuticals Inc -19.91%$ -19.909 
Docgo Inc -25.00%$ -25.000 
Maravai Lifesciences Holdings Inc -26.09%$ -26.087 
Progyny Inc -26.32%$ -26.316 
Zynex inc -27.78%$ -27.778 
Merck and Co Inc -29.28%$ -29.282 
Organon and Co -29.92%$ -29.921 
Abbott Laboratories-30.51%$ -30.508 
Gilead Sciences Inc -30.58%$ -30.583 
West Pharmaceutical Services Inc -31.65%$ -31.646 
Alpha Pro Tech Ltd -33.33%$ -33.333 
Laboratory Corporation Of America Holdings-35.90%$ -35.902 
Lhc Group Inc -35.96%$ -35.955 
Encompass Health Corporation-36.63%$ -36.634 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com